128 results on '"Banke, Ann"'
Search Results
2. Importance of familial predisposition to heart failure to the risk of anthracycline-related cardiotoxicity: A nationwide study
3. Association between speckle tracking echocardiography and pressure-volume loops during cardiogenic shock development
4. Haemodynamic implications of VA‐ECMO vs. VA‐ECMO plus Impella CP for cardiogenic shock in a large animal model.
5. Low body mass index and risk of mortality after mitral transcatheter edge‐to‐edge repair procedure: The "obesity paradox".
6. Impella RP Versus Pharmacologic Vasoactive Treatment in Profound Cardiogenic Shock due to Right Ventricular Failure
7. Biventricular Compared to Left Ventricular Impella and Norepinephrine Support in a Porcine Model of Severe Cardiogenic Shock
8. Biventricular Compared to Left Ventricular Impella and Norepinephrine Support in a Porcine Model of Severe Cardiogenic Shock
9. Long-Term Risk of Heart Failure in Breast Cancer Patients After Adjuvant Chemotherapy With or Without Trastuzumab
10. Unloading using Impella CP during profound cardiogenic shock caused by left ventricular failure in a large animal model: impact on the right ventricle
11. Impact of concomitant vasoactive treatment and mechanical left ventricular unloading in a porcine model of profound cardiogenic shock
12. Impact of Impella RP Versus Vasoactive Treatment on Right and Left Ventricular Strain in a Porcine Model of Acute Cardiogenic Shock Induced by Right Coronary Artery Embolization
13. Impact of Impella RP Versus Vasoactive Treatment on Right and Left Ventricular Strain in a Porcine Model of Acute Cardiogenic Shock Induced by Right Coronary Artery Embolization
14. Importance of familial predisposition to heart failure to the risk of anthracycline-related cardiotoxicity:A nationwide study
15. Hemodynamic Characteristics in Significant Symptomatic and Asymptomatic Primary Mitral Valve Regurgitation at Rest and During Exercise
16. Layer‐specific deformation analysis in severe aortic valve stenosis, primary mitral valve regurgitation, and healthy individuals validated against invasive hemodynamic measurements of heart function
17. IMPACT OF IMPELLA RP VERSUS VASOACTIVE TREATMENT ON LEFT VENTRICULAR STRAIN IN A PORCINE MODEL OF ACUTE CARDIOGENIC SHOCK DUE TO RIGHT CORONARY ARTERY EMBOLIZATION.
18. RENAL ARTERIAL AND VENOUS FLOW VELOCITIES IN VENO-ARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION VERSUS ECMELLA
19. CORRELATION BETWEEN CARDIAC OUTPUT, BLOOD PRESSURE AND RENAL FLOW VELOCITIES IN A PORCINE MODEL OF ACUTE CARDIOGENIC SHOCK
20. Abstract 9321: Cardiac Work and End-Organ Perfusion During Biventricular Compared to Left Ventricular Impella and Norepinephrine Support in a Porcine Model of Severe Cardiogenic Shock
21. Incidence of cancer in patients with chronic heart failure: a long-term follow-up study
22. Immediate evaluation of global longitudinal strain at initiation of trastuzumab treatment in breast cancer patients
23. Immediate evaluation of global longitudinal strain at initiation of trastuzumab treatment in breast cancer patients
24. Hemodynamic determinants of left atrial function in patients with primary mitral regurgitation
25. Early evaluation of global longitudinal strain and biomarkers at initiation of trastuzumab treatment in breast cancer patients
26. Impact of concomitant vasoactive treatment and mechanical left ventricular unloading in a porcine model of profound cardiogenic shock
27. Patient-reported outcomes at hospital discharge among patients with arrhythmia:Results from the national DenHeart survey
28. Unloading using Impella CP during profound cardiogenic shock caused by left ventricular failure in a large animal model:impact on the right ventricle
29. Living with the dilemma of the treatment for human epidermal growth factor receptor 2‐positive breast cancer and the risk of incident heart disease: A qualitative investigation of patients' experiences
30. Patient-reported outcomes at hospital discharge among patients with arrhythmia: Results from the national DenHeart survey
31. Hemodynamic assessment of left atrial function in mitral regurgitation
32. Impella CP or VA-ECMO in profound cardiogenic shock:left ventricular unloading and organ perfusion in a large animal model
33. Long-term effect of epirubicin on incidence of heart failure in women with breast cancer:Insight from a randomized clinical trial
34. Management of cardiovascular complications secondary to medical treatment of cancer
35. Management of cardiovascular complications secondary to medical treatment of cancer
36. Livet med et dilemma - brystkræft og risiko for hjertesygdom:en kvalitativ undersøgelse af patienters oplevelser
37. Impella CP or VA-ECMO in profound cardiogenic shock: left ventricular unloading and organ perfusion in a large animal model
38. Cardiac remodelling and haemodynamic characteristics in primary mitral valve regurgitation
39. Håndtering af hjertekomplikationer sekundært til medicinsk kræftbehandling
40. Patient-reported outcomes at hospital discharge among patients with arrhythmia: Results from the national DenHeart survey.
41. MECHANICAL CIRCULATORY SUPPORT BY VENO-ARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION OR IMPELLA CP IN A PORCINE MODEL OF PROFOUND CARDIOGENIC SHOCK: IMPACT ON LEFT VENTRICULAR UNLOADING AND END ORGAN PERFUSION
42. Long-term effect of epirubicin on incidence of heart failure in women with breast cancer: insight from a randomized clinical trial
43. Incidence of cancer in patients with chronic heart failure:a long-term follow-up study
44. Long-term Effect of Epirubicin on Incidence of Heart Failure in Women with Breast Cancer
45. LONG-TERM EFFECTS OF EPIRUBICIN ON INCIDENCE OF HEART FAILURE IN WOMEN WITH BREAST CANCER: DATA FROM A RANDOMIZED CLINICAL TRIAL
46. PROGNOSIS AFTER A DIAGNOSIS OF CANCER IN CHRONIC HEART FAILURE PATIENTS: A LONG TERM FOLLOW-UP STUDY
47. Atrial fibrillation in severe aortic valve stenosis — Association with left ventricular left atrial remodeling
48. INCREASED INCIDENCE OF CANCER AMONG HEART FAILURE PATIENTS: A LONG-TERM FOLLOW-UP STUDY
49. Excess Risk of Mortality and Hospitalization in Patients with Heart Failure According to Age and Comorbidity - A Nationwide Register Study.
50. [Management of cardiovascular complications secondary to medical treatment of cancer].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.